Is Biogen Inc. overvalued?

Biogen Inc. (BIIB) looks fairly valued — trading about 10% below its fair value.

Fairly valued

Price

$208.87

Fair value

$229.21

Current P/E

23.7

Normal P/E

26.0

Market cap

$30.86B

Dividend yield

0.0%

Return on equity

4.5%

Sector

Healthcare

Fair value compares BIIB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks